Joaquin F Mould-Quevedo (Joaquin Mould-Quevedo, Joaquin F Mould)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 20

Top Topics

Affordable Care Act

Stem Cell Transplantation

Top Venues

Journal of medical virology

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Marc Paccalin, Gaëtan Gavazzi, Quentin Berkovitch, Henri Leleu, Romain Moreau, Emanuele Ciglia, Nansa Burlet, Joaquin F Mould-Quevedo
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France. Vaccines 12 (6) (2024)
Chia-Yu Chi, Ming-Fang Cheng, Karam Ko, Joaquin F Mould-Quevedo, Chih-Jung Chen, Yhu-Chering Huang, Ping-Ing Lee
Cost-effectiveness analysis of cell-based versus egg-based quadrivalent influenza vaccines in the pediatric population in Taiwan. Journal of medical virology 96 (1) (2024)
Marc Paccalin, Gaëtan Gavazzi, Quentin Berkovitch, Henri Leleu, Romain Moreau, Emanuele Ciglia, Nansa Burlet, Joaquin F Mould-Quevedo
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France. Vaccines 12 (6) (2024)
Chia-Yu Chi, Ming-Fang Cheng, Karam Ko, Joaquin F Mould-Quevedo, Chih-Jung Chen, Yhu-Chering Huang, Ping-Ing Lee
Cost-effectiveness analysis of cell-based versus egg-based quadrivalent influenza vaccines in the pediatric population in Taiwan. Journal of medical virology 96 (1) (2024)
Marc Paccalin, Gaëtan Gavazzi, Quentin Berkovitch, Henri Leleu, Romain Moreau, Emanuele Ciglia, Nansa Burlet, Joaquin F Mould-Quevedo
Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France. Vaccines 12 (6) (2024)
Van Hung Nguyen, Mansoor Ashraf, Joaquin F Mould-Quevedo
Estimating the impact of influenza vaccination of low-risk 50-64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK. Human vaccines & immunotherapeutics 19 (1) (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Joaquin F Mould-Quevedo, Stephen I Pelton, Van Hung Nguyen
Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Children: A Narrative Review. Vaccines 11 (10) (2023)
Van Hung Nguyen, Mansoor Ashraf, Joaquin F Mould-Quevedo
Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland. Vaccines 11 (5) (2023)
Van Hung Nguyen, Mansoor Ashraf, Joaquin F Mould-Quevedo
Estimating the impact of influenza vaccination of low-risk 50-64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK. Human vaccines & immunotherapeutics (2023)
Jorge Jacob, Tor Biering-Sørensen, Lars Holger Ehlers, Christina H Edwards, Kristin Greve-Isdahl Mohn, Anna Nilsson, Jonas Hjelmgren, Wenkang Ma, Yuvraj Sharma, Emanuele Ciglia, Joaquin F Mould-Quevedo
Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. Vaccines 11 (4) (2023)
Maarten Postma, David Fisman, Norberto D Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F Mould-Quevedo
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines 11 (6) (2023)
Maarten Postma, David Fisman, Norberto D Giglio, Sergio Márquez-Peláez, Van Hung Nguyen, Andrea Pugliese, Jesús Ruiz-Aragón, Analia Urueña, Joaquin F Mould-Quevedo
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion. Vaccines 11 (6) (2023)
Stephen I Pelton, Joaquin F Mould-Quevedo, Van Hung Nguyen
The Impact of Adjuvanted Influenza Vaccine on Disease Severity in the US: A Stochastic Model. Vaccines 11 (10) (2023)
Michele A Kohli, Michael Maschio, Shannon Cartier, Joaquin F Mould-Quevedo, Frank-Ulrich Fricke
The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany. Vaccines 10 (9) (2022)
Analía Urueña, Paula Micone, María Cecilia Magneres, Ian McGovern, Joaquin F Mould-Quevedo, Túlio Tadeu Rocha Sarmento, Norberto Giglio
Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina. Vaccines 10 (10) (2022)
Van Hung Nguyen, Joaquin F Mould-Quevedo
Estimating the Impact of Influenza Vaccination on Acute and ICU Hospital Bed Usage in an Influenza Season under Endemic COVID-19 in the US. Vaccines 10 (11) (2022)
Min Joo Choi, Jae-Won Yun, Joon Young Song, Karam Ko, Joaquin F Mould-Quevedo, Hee Jin Cheong
A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea. Vaccines 10 (9) (2022)